​

CeriBell (CBLL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CBLL Stock Forecast

CeriBell (CBLL) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $30.00, with a high of $30.00 and a low of $30.00. This represents a 61.55% increase from the last price of $18.57.

CBLL Stock Rating

CeriBell stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

CBLL Price Target Upside V Benchmarks

TypeNameUpside
StockCeriBell61.55%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks35.61%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$30.00
Last Closing Price$18.57$18.57$18.57
Upside/Downside--61.55%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2617---8
Mar, 2617---8
Feb, 2617---8
Jan, 2617---8
Dec, 2517---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 15, 2025Marie ThibaultBTIG$30.00$20.9543.20%61.55%
Nov 05, 2024William PlovanicCanaccord Genuity$30.00$27.2610.05%61.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 15, 2025BTIGBuyBuyhold
Dec 09, 2025Cowen & Co.BuyBuyhold
Nov 05, 2024Cowen & Co.Buyinitialise
Nov 05, 2024Canaccord GenuityBuyinitialise

Financial Forecast

EPS Forecast

Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$-3.39$-1.46--
Avg Forecast$-2.46$-1.18$-0.99$-0.62
High Forecast$-1.34$-1.09$-0.95$-0.59
Low Forecast$-3.07$-1.23$-1.03$-0.64
Surprise %37.80%23.73%--

Revenue Forecast

$60M $77M $94M $111M $128M $145M Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$65.44M$89.06M--
Avg Forecast$64.39M$81.19M$106.04M$138.90M
High Forecast$64.48M$81.50M$106.88M$140.00M
Low Forecast$64.30M$80.87M$105.53M$138.24M
Surprise %1.64%9.70%--

Net Income Forecast

$-75M $-62M $-49M $-36M $-23M $-10M Dec 24 Dec 25 Dec 26 Dec 27
Dec 24Dec 25Dec 26Dec 27
Reported$-40.45M$-53.41M--
Avg Forecast$-36.15M$-26.82M$-22.84M$-14.22M
High Forecast$-30.98M$-25.20M$-21.86M$-13.64M
Low Forecast$-70.98M$-28.44M$-23.81M$-14.80M
Surprise %11.90%99.14%--

CBLL Forecast FAQ

Is CeriBell stock a buy?

CeriBell stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CeriBell is a favorable investment for most analysts.

What is CeriBell's price target?

CeriBell's price target, set by 4 Wall Street analysts, averages $30 over the next 12 months. The price target range spans from $30 at the low end to $30 at the high end, suggesting a potential 61.55% change from the previous closing price of $18.57.

How does CeriBell stock forecast compare to its benchmarks?

CeriBell's stock forecast shows a 61.55% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (35.61%).

What is the breakdown of analyst ratings for CeriBell over the past three months?

  • April 2026: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 12.50% Strong Buy, 87.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is CeriBell’s EPS forecast?

CeriBell's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.99, marking a -32.19% decrease from the reported $-1.46 in 2025. Estimates for the following years are.

What is CeriBell’s revenue forecast?

CeriBell's average annual revenue forecast for its fiscal year ending in December 2026 is $106.04M, reflecting a 19.06% increase from the reported $89.06M in 2025. The forecast for.

What is CeriBell’s net income forecast?

CeriBell's net income forecast for the fiscal year ending in December 2026 stands at $-22.837M, representing a -57.24% decrease from the reported $-53.412M in 2025. Projections indicate .